Startups
Edit
Roche Venture Fund
https://www.venturefund.roche.com/Last activity: 05.01.2016
Probably Closed
Mentions in press and media 13
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 14, 2015 | Minoryx Therapeutics completes Series A funding of €19.4M ($21.7M) | Minoryx Therapeutics, a drug development company specialized in the discovery of new drugs for orphan diseases, today announces it has completed a Series A funding round of €19.4M ($21.7M). Ysios Capital, a Spanish investment fund, led the ... |
| Oct 9, 2015 | Daily funding roundup - October 14, 2015 | Area 1 Security raised $15M eMMs, Inc. secured over $2 million in company's Series-A round of funding from private South African individual investor to build the cyber data protection fortress, FortKnoxx. Patent pending, FortKnoxx Fortress ... |
| Sep 9, 2015 | Daily funding roundup - September 9, 2015 | Didi Kuaidi scored $1B; Chef bagged $40M; Primus Power raised $25M The battle for supremacy among e-hailing services in China is heating up, and fast. In the same week that Uber revealed that it has raised an additional $1.2 billion to expa... |
| Jan 9, 2015 | AveXis Raises $10M in Funding | AveXis, a Dallas, Texas-based gene therapy-focused biotech company, raised $10m in funding. The round was led by Deerfield Management and Roche Venture Fund. In conjunction with the funding, Jonathan Leff of Deerfield and Carole Nuechterlei... |
| Apr 29, 2013 | Opsona Therapeutics Raises €33M in Series C Financing | Opsona Therapeutics, a Dublin, Ireland-based developer of new treatments for inflammatory diseases, raised €33m (US$43m) in Series C financing. The round was led by BB Biotech Ventures and Novartis Venture Fund, with participation from new ... |
| Dec 17, 2012 | Allakos Completes $32M Series A Financing | Allakos Inc., a San Francisco Bay Area-based biotechnology company, has completed a $32m Series A financing. The round was led by Novo Ventures with participation from Alta Partners, RiverVest Venture Partners and the Roche Venture Fund. In... |
| Nov 13, 2012 | Cancer diagnostics firm that can enable personalized medicine raises $13M in series B financing | “Epic’s technology has achieved an unprecedented level of sensitivity in detecting circulating tumor cells to develop crucial cancer diagnostics for the millions of patients who need to understand whether their treatment is working and the ... |
| Nov 13, 2012 | Epic Sciences Completes $13M Series B Equity Financing | Epic Sciences, Inc., a San Diego, CA-based biotech company that develops cancer diagnostics, has completed a $13m Series B equity financing. Backers include new investors Domain Associates, Roche Venture Fund, and Pfizer Venture Investments... |
| Aug 26, 2011 | MISSION Therapeutics Raises £6M in Series A Funding | MISSION Therapeutics Ltd, a Cambridge, UK-based newly formed company that is developing a broad platform of technologies for the discovery and development of targeting enzymes involved in cancer and other diseases, has raised £6m in a Serie... |
Show more
Reviews 0
FAQ about Roche Venture Fund
What has the press written about Roche Venture Fund?
Parsers VC has collected 13 articles mentioning Roche Venture Fund, among them “Minoryx Therapeutics completes Series A funding of €19.4M ($21.7M)” (Oct 14, 2015) and “Daily funding roundup - October 14, 2015” (Oct 9, 2015).
Is Roche Venture Fund still active?
Roche Venture Fund is probably closed: its latest activity on Parsers VC dates from Jan 5, 2016.